+5.6%
CVS vs EXE
-18.4%
+24.0%
-26.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -12.5% | -2.9% | -9.6% | -12.1% |
| 7D | -11.1% | -4.7% | -6.5% | -10.5% |
| 30D | -7.4% | +1.0% | -8.5% | -7.4% |
| 3M | -22.9% | -5.6% | -17.3% | -22.2% |
| 6M | -1.2% | -12.3% | +11.1% | +0.6% |
| YTD | +3.9% | -19.5% | +23.3% | +7.1% |
| 1Y | +5.6% | -18.9% | +24.4% | +6.5% |
| All | +5.6% | -18.4% | +24.0% | +6.5% |
Cumulative growth
Daily Returns
Daily percentage return beside EXE.
Daily Out/Under-Performance
Portfolio return minus EXE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling